Delayed presentation of biopsy-proven eosinophilic myocarditis following COVID-19 mRNA vaccine.

Publication/Presentation Date

5-11-2023

Abstract

Myopericarditis associated with COVID-19 mRNA vaccines has been recognized as an uncommon adverse reaction, especially among young, healthy adult males. Eosinophilic myocarditis is a rare form of inflammation reflecting a hypersensitivity reaction following an inciting event commonly caused by drugs including vaccines. Eosinophilic myocarditis, a subtype of myocarditis, is characterized by eosinophilic myocardial infiltrates. It is usually accompanied by systemic eosinophilia in the form of a drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and is rarely associated with myocyte fibrosis and/or necrosis. In this report, we present a case of biopsy-proven eosinophilic myocarditis in a 24-year-old male patient, likely secondary to COVID-19 mRNA vaccination. To our knowledge, this is the first report to describe delayed eosinophilic myocarditis following the COVID-19 mRNA vaccine. Clinicians should be aware of possible delayed presentation to avoid associated morbidity.

Volume

2023

Issue

2

First Page

202310

Last Page

202310

ISSN

2305-7823

Disciplines

Medicine and Health Sciences

PubMedID

37351099

Department(s)

Fellows and Residents

Document Type

Article

Link to Full Text

Share

COinS